Douglas Lane Adds $6 Million in J&J Stock Ahead of Earnings and Possible Biotech Deal

Douglas Lane & Associates, LLC disclosed a purchase of 34,948 shares of Johnson & Johnson (NYSE:JNJ) in an SEC filing on Friday, representing an estimated $6 million transaction based on average prices during the third quarter.According to an SEC filing released on Friday, Douglas Lane & Associates increased its position in Johnson & Johnson by acquiring 34,948 additional shares in the third quarter. The estimated transaction value, based on the average unadjusted closing price during the period, was $6 million. The new stake totals 667,373 shares, with a reported market value of $123.7 million at quarter-end.Post-trade, the JNJ stake represents 1.7% of Douglas Lane's reported assets.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool